Fibrates improve liver tests in primary sclerosing cholangitis with incomplete biochemical response to ursodeoxycholic acid: update of a pilote study

被引：0
|
作者：
Lemoinne, Sara [1 ,2 ,3 ]
Corpechot, Christophe [1 ,2 ,3 ]
Fankem, Astrid Donald D. Kemgang [1 ,2 ,3 ]
Gaouar, Farid [1 ]
Poupon, Raoul [1 ,2 ,3 ]
Chazouilleres, Olivier [1 ,2 ,3 ]
机构：
[1] Hop St Antoine, AP HP, Serv Hepatol, Ctr Reference Malad Inflammatoires Voies Biliaire, F-75571 Paris, France
[2] INSERM, UMRS 938, F-75012 Paris, France
[3] Univ Paris 06, F-75012 Paris, France
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
335
引用
收藏
页码：368A / 368A
页数：1
相关论文
共 50 条
  • [1] FENOFIBRATE IMPROVES LIVER TESTS IN PRIMARY SCLEROSING CHOLANGITIS WITH INCOMPLETE BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID
    Chazouilleres, Olivier
    Corpechot, Christophe
    Gaouar, Farid
    Poupon, Raoul
    HEPATOLOGY, 2010, 52 (04) : 488A - 488A
  • [2] Long term impact of fibrates in primary sclerosing cholangitis with incomplete biochemical response to ursodeoxycholic acid : the French-Spanish experience
    Lemoinne, Sara
    Corpechot, Christophe
    Fankem, Astrid Donald D. Kemgang
    Gaouar, Farid
    Poupon, Raoul
    Housset, Chantal
    Pares, Albert
    Chazouilleres, Olivier
    HEPATOLOGY, 2015, 62 : 529A - 529A
  • [3] Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French-Spanish experience
    Lemoinne, Sara
    Pares, Albert
    Reig, Anna
    Ben Belkacem, Karima
    Fankem, Astrid Donald Kemgang
    Gaouar, Farid
    Poupon, Raoul
    Housset, Chantal
    Corpechot, Christophe
    Chazouilleres, Olivier
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (06) : 521 - 528
  • [4] ADEQUATE BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS: IS NORMALIZATION OF SERUM LIVER TESTS IMPORTANT?
    Corpechot, Christophe
    Lemoinne, Sara
    Hansen, Bettina E.
    Hirschfield, Gideon
    Gulamhusein, Aliya
    Montano-Loza, Aldo J.
    Lytvyak, Ellina
    Schramm, Christoph
    Pares, Albert
    Olivas, Ignasi
    Eaton, John E.
    Osman, Karim
    Dalekos, George N.
    Gatselis, Nikolaos K.
    Nevens, Frederik
    Cazzagon, Nora
    Zago, Alessandra
    Russo, Francesco Paolo
    Abbas, Nadir
    Trivedi, Palak
    Thorburn, Douglas
    Saffioti, Francesca
    Barkai, Lazlo
    Roccarina, Davide
    Calvaruso, Vincenza
    Fichera, Anna
    Medina-Morales, Esli
    Bonder, Alan
    Patwardhan, Vilas
    Villamil, Alejandra Gracia
    Sobenko, Natalia
    Rigamonti, Cristina
    Carbone, Marco
    Invernizzi, Pietro
    Cristoferi, Laura
    Van der Meer, Adriaan
    De Veer, Rozanne
    Zigmond, Ehud
    Yehezkel, Eyal
    Kremer, Andreas E.
    Deibel, Ansgar
    Bruns, Tony
    Grosse, Karsten
    Wetten, Aaron
    Dyson, Jessica
    Jones, David
    Dumortier, Jerome
    Pageaux, Georges-Philippe
    De Ledinghen, Victor
    Chazouilleres, Olivier
    HEPATOLOGY, 2022, 76 : S1480 - S1481
  • [5] An Open-Label Study of Abatacept in Patients with Primary Biliary Cholangitis with an Incomplete Biochemical Response to Ursodeoxycholic Acid
    Liu, Chung H.
    Yang, Guo-Xiang
    Johnson, Cole R.
    Dhaliwal, Sandeep S.
    Levy, Cynthia
    Peters, Marion G.
    Vierling, John M.
    Gershwin, M. Eric
    Bowlus, Christopher L.
    HEPATOLOGY, 2017, 66 : 160A - 160A
  • [6] Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: A pilot study
    Lindor, KD
    Jorgensen, RA
    Anderson, ML
    Gores, GJ
    Hofmann, AF
    LaRusso, NF
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (03): : 511 - 515
  • [7] Long-term treatment with fibrates and ursodeoxycholic acid in people with Primary Sclerosing Cholangitis is safe and associated with persistent clinical and biochemical improvement
    Catanzaro, E.
    Peviani, M.
    Perin, N.
    Bonaiuto, E.
    Simionato, F.
    Motta, R.
    Gambato, M.
    Floreani, A.
    Cazzagon, N.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S59 - S60
  • [8] Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
    Cancado, Guilherme Grossi Lopes
    Couto, Claudia Alves
    Guedes, Laura Vilar
    Braga, Michelle Harriz
    Terrabuio, Debora Raquel Benedita
    Cancado, Eduardo Luiz Rachid
    Ferraz, Maria Lucia Gomes
    Villela-Nogueira, Cristiane Alves
    Nardelli, Mateus Jorge
    Faria, Luciana Costa
    Oliveira, Elze Maria Gomes de
    Rotman, Vivian
    Mazo, Daniel Ferraz de Campos
    Borges, Valeria Ferreira de Almeida e
    Mendes, Liliana Sampaio Costa
    Codes, Liana
    Pessoa, Mario Guimaraes
    Signorelli, Izabelle Venturini
    Levy, Cynthia
    Bittencourt, Paulo Lisboa
    FRONTIERS IN PHARMACOLOGY, 2022, 12
  • [9] Histological characteristics of primary biliary cholangitis with an incomplete response to ursodeoxycholic acid
    Harada, Kenichi
    Kakuda, Yuko
    Tanaka, Atsushi
    Abe, Masanori
    Namisaki, Tadashi
    Shimoda, Shinji
    Zeniya, Mikio
    Ido, Akio
    Yoshiji, Hitoshi
    Ohira, Hiromasa
    Umeda, Atsushi
    Kamiya, Yuki
    Higashine, Yukari
    Hojo, Seiichiro
    Imai, Toshio
    Kawano, Tetsu
    Tsubouchi, Hirohito
    Nakanuma, Yasuni
    JOURNAL OF HEPATOLOGY, 2020, 73 : S477 - S477
  • [10] Primary sclerosing cholangitis: Conventional and quantitative liver function tests during long-term therapy with ursodeoxycholic acid
    vonSchonfeld, J
    Zotz, R
    Mahl, M
    Beste, M
    Breuer, N
    Goebell, H
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (02): : 123 - 127
12345